Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2022-01-01 00:00:00

The Gut Microbiome in Parkinson’s Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies

2022-01-01 00:00:00

Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain

2022-01-01 00:00:00

Oral and gut dysbiosis leads to functional alterations in Parkinson’s disease

2022-01-01 00:00:00

Gut Microbiota in Monozygotic Twins Discordant for Parkinson’s Disease

2022-01-01 00:00:00

Fecal microbiome alterations in treatment-naive de novo Parkinson’s disease

2022-01-01 00:00:00

Metagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms

2022-01-01 00:00:00

Parkinson’s Disease and the Gut Microbiome in Rural California

2022-01-01 00:00:00

Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis

2022-01-01 00:00:00

A cross-sectional analysis about bacterial vaginosis, high-risk human papillomavirus infection, and cervical intraepithelial neoplasia in Chinese women

2022-01-01 00:00:00

Composition and Functional Potential of the Human Mammary Microbiota Prior to and Following Breast Tumor Diagnosis

← Prev 1 …33 34 35 36 37 …47 Next →